These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 35346718)

  • 61. A randomised placebo-controlled double-blind trial to assess the safety of intramuscular administration of allogeneic mesenchymal stromal cells for digital ulcers in systemic sclerosis: the MANUS Trial protocol.
    van Rhijn-Brouwer FCC; Gremmels H; Fledderus JO; Schuurman AH; Bonte-Mineur F; Vonk MC; Voskuyl AE; de Vries-Bouwstra JK; Coert JH; Radstake TRDJ; van Laar JM; Verhaar MC;
    BMJ Open; 2018 Aug; 8(8):e020479. PubMed ID: 30127049
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Sudden winter iloprost withdrawal in scleroderma patients during COVID-19 pandemic.
    De Lorenzis E; Natalello G; Verardi L; Cerasuolo PG; Gigante L; D'Agostino MA; Bosello SL
    Microvasc Res; 2022 Nov; 144():104404. PubMed ID: 35835174
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Use of platelet inhibitors for digital ulcers related to systemic sclerosis: EUSTAR study on derivation and validation of the DU-VASC model.
    Garaiman A; Steigmiller K; Gebhard C; Mihai C; Dobrota R; Bruni C; Matucci-Cerinic M; Henes J; de Vries-Bouwstra J; Smith V; Doria A; Allanore Y; Dagna L; Anić B; Montecucco C; Kowal-Bielecka O; Martin M; Tanaka Y; Hoffmann-Vold AM; Held U; Distler O; Becker MO;
    Rheumatology (Oxford); 2023 Feb; 62(SI):SI91-SI100. PubMed ID: 35904554
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Developing a core set of outcome measure domains to study Raynaud's phenomenon and digital ulcers in systemic sclerosis: Report from OMERACT 2020.
    Maltez N; Hughes M; Brown E; Hickey V; Park H; Shea B; Herrick AL; Pauling JD; Proudman S; Merkel PA
    Semin Arthritis Rheum; 2021 Jun; 51(3):640-643. PubMed ID: 33947582
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Blood flow in the hands of a predefined homogeneous systemic sclerosis population: the presence of digital ulcers and the improvement with bosentan.
    Meijs J; Voskuyl AE; Bloemsaat-Minekus JP; Vonk MC
    Rheumatology (Oxford); 2015 Feb; 54(2):262-9. PubMed ID: 25150178
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Circulating galectin-1 concentrations in systemic sclerosis: potential contribution to digital vasculopathy.
    Yanaba K; Asano Y; Akamata K; Noda S; Aozasa N; Taniguchi T; Takahashi T; Toyama T; Ichimura Y; Sumida H; Kuwano Y; Miyazaki M; Sato S
    Int J Rheum Dis; 2016 Jun; 19(6):622-7. PubMed ID: 24517166
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Impact of digital ulcers on disability and health-related quality of life in systemic sclerosis.
    Mouthon L; Mestre-Stanislas C; Bérezné A; Rannou F; Guilpain P; Revel M; Pagnoux C; Guillevin L; Fermanian J; Poiraudeau S
    Ann Rheum Dis; 2010 Jan; 69(1):214-7. PubMed ID: 19221115
    [TBL] [Abstract][Full Text] [Related]  

  • 68. A clinical comparison of an endothelin receptor antagonist and phosphodiesterase type 5 inhibitors for treating digital ulcers of systemic sclerosis.
    Chang SH; Jun JB; Lee YJ; Kang TY; Moon KW; Ju JH; Kang SW; Choi IA; Park YB; Lee SG; Lee SS; Heo NH; Lee EB
    Rheumatology (Oxford); 2021 Dec; 60(12):5814-5819. PubMed ID: 33576774
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Telangiectasia as a potential clinical marker of microvascular lesions in systemic sclerosis patients from EUSTAR data in China.
    Zhang SZ; Xu D; Li MT; Hou Y; Wang Q; Tian Z; Liu YT; Guo XX; Lai JZ; Zhao JL; Hu CJ; Song N; Sun QN; Zhang FC; Zhao Y; Zeng XF
    Clin Exp Rheumatol; 2015; 33(4 Suppl 91):S106-10. PubMed ID: 26005882
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Predictive role of capillaroscopic skin ulcer risk index in systemic sclerosis: a multicentre validation study.
    Sebastiani M; Manfredi A; Vukatana G; Moscatelli S; Riato L; Bocci M; Iudici M; Principato A; Mazzuca S; Del Medico P; De Angelis R; D'Amico R; Vicini R; Colaci M; Ferri C
    Ann Rheum Dis; 2012 Jan; 71(1):67-70. PubMed ID: 21917823
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Preliminary analysis of the very early diagnosis of systemic sclerosis (VEDOSS) EUSTAR multicentre study: evidence for puffy fingers as a pivotal sign for suspicion of systemic sclerosis.
    Minier T; Guiducci S; Bellando-Randone S; Bruni C; Lepri G; Czirják L; Distler O; Walker UA; Fransen J; Allanore Y; Denton C; Cutolo M; Tyndall A; Müller-Ladner U; Matucci-Cerinic M; ;
    Ann Rheum Dis; 2014 Dec; 73(12):2087-93. PubMed ID: 23940211
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Clinical features of scleroderma patients with or without prior or current ischemic digital ulcers: post-hoc analysis of a nationwide multicenter cohort (ItinérAIR-Sclérodermie).
    Tiev KP; Diot E; Clerson P; Dupuis-Siméon F; Hachulla E; Hatron PY; Constans J; Cirstéa D; Farge-Bancel D; Carpentier PH
    J Rheumatol; 2009 Jul; 36(7):1470-6. PubMed ID: 19487271
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Serum heparanase levels: A protective marker against digital ulcers in patients with systemic sclerosis.
    Wu CY; Asano Y; Taniguchi T; Sato S; Yu HS
    J Dermatol; 2015 Jun; 42(6):625-8. PubMed ID: 25808574
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Vitamin D serum levels and the risk of digital ulcers in systemic sclerosis: A longitudinal study.
    Caimmi C; Bertoldo E; Pozza A; Caramaschi P; Orsolini G; Gatti D; Rossini M; Viapiana O
    Int J Rheum Dis; 2019 Jun; 22(6):1041-1045. PubMed ID: 30938067
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Efficacy of local oxygen-ozone therapy for the treatment of digital ulcer refractory to medical therapy in systemic sclerosis: A randomized controlled study.
    Kaymaz S; Karasu U; Alkan H; Ulutaş F; Albayrak Yaşar C; Dündar Ök Z; Çobankara V; Yiğit M; Yıldız N; Ardıç F
    Mod Rheumatol; 2022 Oct; 32(6):1102-1107. PubMed ID: 34865095
    [TBL] [Abstract][Full Text] [Related]  

  • 76. A 3-factor epistatic model predicts digital ulcers in Italian scleroderma patients.
    Beretta L; Santaniello A; Mayo M; Cappiello F; Marchini M; Scorza R
    Eur J Intern Med; 2010 Aug; 21(4):347-53. PubMed ID: 20603050
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Use of vasoactive/vasodilating drugs for systemic sclerosis (SSc)-related digital ulcers (DUs) in expert tertiary centres: results from the analysis of the observational real-life DeSScipher study.
    Blagojevic J; Abignano G; Avouac J; Cometi L; Frerix M; Bellando-Randone S; Guiducci S; Bruni C; Huscher D; Jaeger VK; Lóránd V; Maurer B; Nihtyanova S; Riemekasten G; Siegert E; Tarner IH; Vettori S; Walker UA; Czirják L; Denton CP; Distler O; Allanore Y; Müller-Ladner U; Moggi-Pignone A; Matucci-Cerinic M; Del Galdo F;
    Clin Rheumatol; 2020 Jan; 39(1):27-36. PubMed ID: 31111363
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Endothelial Dysfunction and Nailfold Videocapillaroscopy Pattern as Predictors of Digital Ulcers in Systemic Sclerosis: a Cohort Study and Review of the Literature.
    Silva I; Teixeira A; Oliveira J; Almeida I; Almeida R; Águas A; Vasconcelos C
    Clin Rev Allergy Immunol; 2015 Oct; 49(2):240-52. PubMed ID: 26142066
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Vascular biomarkers and digital ulcerations in systemic sclerosis: results from a randomized controlled trial of oral treprostinil (DISTOL-1).
    Mecoli CA; Perin J; Van Eyk JE; Zhu J; Fu Q; Allmon AG; Rao Y; Zeger S; Wigley FM; Hummers LK; Shah AA
    Clin Rheumatol; 2020 Apr; 39(4):1199-1205. PubMed ID: 31858338
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Digital ulcer debridement in systemic sclerosis: a systematic literature review.
    Hughes M; Alcacer-Pitarch B; Gheorghiu AM; Praino E; Sandler RD; Tavor Y; Bruni C; Matucci-Cerinic M
    Clin Rheumatol; 2020 Mar; 39(3):805-811. PubMed ID: 31955323
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.